Are Results of Arthroscopic Labral Repair Durable in Dysplasia at Midterm Follow-Up? A 2-Center Matched Cohort Analysis
Authors: Hevesi M, Hartigan DE, Wu IT, Levy BA, Domb BG, Krych AJ
Journal: Am J Sports Med. 2018 Jun;46(7):1674-1684.
DOI: 10.1177/0363546518767399 | PMID: 29723044
Background
Evaluates midterm durability of arthroscopic labral repair in patients with hip dysplasia (LCEA < 25°) compared to matched controls without dysplasia.
Methods
Patients with hip dysplasia undergoing arthroscopic labral repair were matched to controls and followed for a mean of 5.7 years. Outcomes assessed included VAS, mHHS, and HOS-SSS.
Key Findings
- Dysplastic patients showed comparable improvements in PROs to controls.
- 5-year failure-free survival was 83.3% in dysplasia group vs. 78.1% in controls.
- BMI ≤30 was paradoxically associated with higher revision risk.
Conclusions
Arthroscopic labral repair can yield favorable, durable midterm outcomes in carefully selected dysplastic patients similar to non-dysplastic controls.
What Does This Mean for Providers?
Providers should consider arthroscopic labral repair as a viable option in hip dysplasia with appropriate patient selection. Close attention to patient factors such as BMI and joint morphology is critical to optimize outcomes and minimize revision risk. Long-term monitoring remains important to detect failures early.